Phase II/III randomized trial of TCH346 in patients with ALS Academic Article uri icon

Overview

MeSH Major

  • Amyotrophic Lateral Sclerosis
  • Apoptosis
  • Nerve Degeneration
  • Oxepins

abstract

  • The trial revealed no evidence of a beneficial effect of TCH346 on disease progression in patients with ALS.

authors

publication date

  • August 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1212/01.wnl.0000269676.07319.09

PubMed ID

  • 17709710

Additional Document Info

start page

  • 776

end page

  • 84

volume

  • 69

number

  • 8